How should chronic iron deficiency anemia associated with uterine fibroids be evaluated and managed?

Management of Chronic Iron Deficiency Anemia from Uterine Fibroids

In women with chronic iron deficiency anemia from uterine fibroids, you must simultaneously treat the iron deficiency with oral or intravenous iron replacement AND address the underlying fibroid-related bleeding through medical or procedural interventions, with treatment choice guided by symptom severity, fibroid characteristics, and fertility goals.

Initial Diagnostic Evaluation

Confirm Iron Deficiency Anemia

• Use ferritin <45 ng/mL as your diagnostic threshold for iron deficiency (sensitivity 85%, specificity 92%) rather than the older <15 ng/mL cutoff 1
• In patients with chronic inflammation or kidney disease, add serum iron, transferrin saturation, or soluble transferrin receptor to confirm true iron deficiency 1

Rule Out GI Sources

Before attributing anemia solely to fibroids, you must exclude gastrointestinal bleeding, particularly in postmenopausal women or men with iron deficiency anemia. The AGA strongly recommends bidirectional endoscopy (EGD and colonoscopy) in these populations, as lower GI malignancy is found in 8.9% and upper GI malignancy in 2.0% of cases 1. However, in premenopausal women with documented menorrhagia and fibroids, GI evaluation can be deferred unless symptoms suggest GI pathology.

Characterize the Fibroids

• Start with transvaginal ultrasound to determine fibroid size, number, and location 2
• Consider 3D ultrasound or saline infusion sonohysterography (SIS) if submucosal fibroids are suspected, as these have the highest correlation with abnormal bleeding 2
• SIS shows excellent agreement (kappa 0.80) with hysteroscopy for classifying submucosal fibroids 2
• Hysteroscopy should be included in your evaluation, as it reveals treatable intrauterine lesions (submucous myomas in 38%, polyps in 13%) in over half of premenopausal women with abnormal bleeding and iron deficiency anemia 3

Iron Replacement Strategy

Initiate Iron Therapy Immediately

Iron replacement must begin during evaluation and continue throughout fibroid treatment 4, 5. The choice between oral and intravenous iron depends on:

• Severity of anemia: Moderate to severe anemia (hemoglobin <10 g/dL) or symptomatic patients benefit from IV iron for faster repletion 6
• Ongoing blood loss: Active heavy menstrual bleeding may outpace oral iron absorption
• Tolerance: GI side effects limit oral iron adherence in many patients
• Urgency: Patients with cardiovascular compromise may require blood transfusion alongside iron therapy, though transfusion alone provides inadequate elemental iron 6

Continue iron supplementation both before and after any surgical procedure to optimize hemoglobin and replenish stores 4.

Addressing the Fibroid-Related Bleeding

Your treatment approach must be individualized based on three key factors: fertility goals, symptom severity, and fibroid characteristics 5.

Medical Management Options

For patients desiring uterine preservation or fertility:

First-line symptomatic agents:

• Tranexamic acid reduces menstrual blood loss without hormonal effects
• NSAIDs provide modest reduction in bleeding and help with dysmenorrhea 4

Hormonal therapies:

• Levonorgestrel intrauterine system (LNG-IUS) is highly effective for bleeding control
• Combined oral contraceptives can reduce menstrual flow
• GnRH agonists or antagonists provide temporary shrinkage but are limited by side effects and cost 4, 5
• Selective progesterone receptor modulators (where available) offer fibroid shrinkage with fewer hypoestrogenic effects 4

Critical caveat: Most medical therapies manage symptoms rather than cure fibroids. Bleeding typically recurs after discontinuation of hormonal treatments 4.

Surgical and Procedural Options

For patients desiring fertility preservation:

• Myomectomy (abdominal, laparoscopic, or hysteroscopic depending on fibroid location) removes fibroids while preserving the uterus 5
• Hysteroscopic resection is ideal for submucosal fibroids causing bleeding 3

For patients not desiring fertility:

• Hysterectomy is curative and accounts for one-third to one-half of the 600,000 annual hysterectomies in the US 2
• Uterine artery embolization (UAE) shows equivalent symptomatic improvement to myomectomy at 2 years 2
• MR-guided focused ultrasound (MRgFUS) and radiofrequency ablation are emerging options 2, 4
• Endometrial ablation can reduce bleeding in selected cases 2

Decision Algorithm

1. Asymptomatic or mild symptoms + no fertility concerns: Medical management with LNG-IUS or hormonal therapy plus iron replacement
2. Moderate-severe bleeding + fertility desired: Myomectomy (route determined by fibroid location) with preoperative iron optimization
3. Severe symptoms + no fertility desired: Hysterectomy or UAE, with choice based on patient preference and surgical candidacy
4. Submucosal fibroids identified on hysteroscopy: Hysteroscopic resection offers definitive treatment for this bleeding source 3

Common Pitfalls to Avoid

• Don't assume fibroids are the sole cause of anemia in postmenopausal women—always exclude GI malignancy with bidirectional endoscopy 1
• Don't rely on ferritin <15 ng/mL as your diagnostic threshold—this misses 41% of iron deficiency cases 1
• Don't forget to continue iron replacement after fibroid treatment—stores must be fully replenished 4, 5
• Don't overlook hysteroscopy in the evaluation—it identifies treatable intrauterine pathology in >50% of cases 3
• Be aware of rare myomatous erythrocytosis syndrome in patients with giant fibroids who present with elevated rather than low hemoglobin—these patients face high risks of perioperative bleeding and thrombosis 7

Quality of Life Considerations

The economic burden of symptomatic fibroids ranges from $5.9 to $34.4 billion annually in the US, with lost work productivity accounting for the largest proportion 2. Treatment decisions should weigh the substantial impact on quality of life, work capacity, and daily functioning against the risks and costs of intervention. Untreated iron deficiency anemia causes fatigue, reduced exercise tolerance, and impaired cognitive function that significantly diminish quality of life 6.